Cancer Incidence and Mortality among Whites, New York City, 2014-2018

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 23936.8 453.6 450.9-456.2 11480.8 484.8 480.8-488.8 12456.0 439.3 435.8-442.9 7397.0 133.8 132.4-135.2 3640.6 156.4 154.1-158.7 3756.4 118.7 117.0-120.5
Oral cavity and pharynx 539.0 10.1 9.8-10.5 358.2 14.9 14.2-15.6 180.8 6.2 5.8-6.6 114.6 2.1 1.9-2.3 79.0 3.4 3.0-3.7 35.6 1.1 1.0-1.3
Esophagus 190.6 3.5 3.3-3.7 138.6 5.8 5.4-6.3 52.0 1.7 1.5-1.9 150.2 2.7 2.5-2.9 109.2 4.6 4.2-5.0 41.0 1.2 1.1-1.4
Stomach 469.2 8.9 8.5-9.2 266.4 11.4 10.8-12.1 202.8 6.9 6.4-7.3 229.0 4.2 4.0-4.5 132.6 5.7 5.3-6.2 96.4 3.1 2.8-3.4
Colorectal 1960.4 36.9 36.2-37.7 1019.6 43.5 42.3-44.7 940.8 31.8 30.9-32.7 698.2 12.5 12.1-12.9 348.0 14.9 14.2-15.7 350.2 10.7 10.2-11.2
Colon excluding rectum 1391.0 26.0 25.3-26.6 706.2 30.3 29.3-31.3 684.8 22.7 21.9-23.5 572.2 10.2 9.8-10.6 281.6 12.1 11.5-12.7 290.6 8.8 8.4-9.3
Rectum & rectosigmoid 569.4 11.0 10.6-11.4 313.4 13.3 12.6-13.9 256.0 9.1 8.6-9.6 126.0 2.3 2.1-2.5 66.4 2.8 2.5-3.2 59.6 1.9 1.7-2.1
Liver / intrahepatic bile duct 542.4 9.9 9.5-10.3 378.2 15.4 14.7-16.1 164.2 5.3 5.0-5.7 352.6 6.4 6.1-6.7 229.8 9.5 8.9-10.1 122.8 3.8 3.5-4.2
Pancreas 760.8 13.8 13.4-14.3 381.2 16.2 15.5-17.0 379.6 11.9 11.4-12.5 604.6 10.8 10.4-11.2 298.6 12.8 12.1-13.5 306.0 9.3 8.9-9.8
Larynx 155.4 2.9 2.7-3.1 122.8 5.1 4.7-5.6 32.6 1.1 1.0-1.3 47.4 0.9 0.8-1.0 40.0 1.7 1.5-1.9 7.4 0.2 0.2-0.3
Lung and bronchus 2598.6 47.7 46.9-48.5 1271.6 54.2 52.9-55.6 1327.0 43.2 42.1-44.2 1466.8 26.4 25.8-27.1 756.2 32.4 31.4-33.5 710.6 22.1 21.4-22.9
Melanoma of the skin 847.4 16.1 15.6-16.6 473.0 20.3 19.5-21.2 374.4 13.2 12.6-13.8 83.8 1.5 1.4-1.7 52.6 2.3 2.0-2.6 31.2 1.0 0.8-1.2
Female breast             3552.2 130.8 128.9-132.9             572.6 18.7 18.0-19.4
Cervix uteri             193.4 7.7 7.2-8.2             62.6 2.3 2.0-2.6
Corpus uterus and NOS             879.4 30.8 29.9-31.8             175.6 5.7 5.3-6.1
Ovary             339.6 12.2 11.6-12.8             210.4 6.9 6.5-7.3
Prostate       2548.6 103.8 102.0-105.7             370.4 16.3 15.5-17.0      
Testis       160.2 6.6 6.2-7.1             5.0 0.2 0.1-0.3      
Urinary bladder (incl. in situ) 1138.6 20.7 20.2-21.3 856.2 36.9 35.8-38.0 282.4 9.0 8.5-9.5 231.0 4.0 3.8-4.2 160.0 7.0 6.5-7.5 71.0 2.0 1.8-2.3
Kidney and renal pelvis 798.4 15.3 14.8-15.8 514.6 21.6 20.8-22.5 283.8 10.0 9.5-10.6 151.6 2.8 2.6-3.0 99.6 4.3 3.9-4.7 52.0 1.6 1.4-1.8
Brain and other central nervous system 354.2 7.2 6.8-7.5 195.4 8.5 8.0-9.0 158.8 6.0 5.6-6.5 205.0 3.9 3.7-4.2 109.8 4.7 4.3-5.1 95.2 3.3 3.0-3.6
Thyroid 1069.2 22.2 21.6-22.8 270.4 11.5 10.9-12.2 798.8 32.7 31.6-33.7 31.0 0.6 0.5-0.7 10.0 0.4 0.3-0.6 21.0 0.6 0.5-0.8
Hodgkin lymphoma 162.8 3.4 3.2-3.7 90.6 4.0 3.6-4.4 72.2 3.0 2.6-3.3 19.8 0.4 0.3-0.5 11.0 0.5 0.4-0.6 8.8 0.3 0.2-0.4
Non-Hodgkin lymphomas 1180.0 22.5 21.9-23.1 626.6 26.9 26.0-27.9 553.4 19.0 18.3-19.7 292.8 5.3 5.0-5.6 160.4 7.0 6.5-7.5 132.4 4.0 3.7-4.4
Myeloma 408.0 7.5 7.2-7.9 230.2 9.7 9.2-10.3 177.8 5.8 5.5-6.3 146.0 2.6 2.4-2.8 80.4 3.4 3.1-3.8 65.6 2.0 1.8-2.3
Leukemias 845.2 16.3 15.8-16.8 475.8 20.7 19.9-21.6 369.4 12.9 12.3-13.5 328.0 6.0 5.7-6.3 173.0 7.6 7.1-8.1 155.0 4.9 4.6-5.3

Notes

  • Incidence data are provisional, November 2020.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.